Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › COGT

SUPERSTRING CAPITAL MANAGEMENT LP position in COGT

COGENT BIOSCIENCES INC · Health Care

SUPERSTRING CAPITAL MANAGEMENT LP reported holding 343,284 shares of COGT (COGENT BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$13.3M, representing 8.39% of its reported portfolio and ranking #1 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed COGT holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)343.28K sh
Reported value held$13.29M
Portfolio Weight8.39%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SUPERSTRING CAPITAL MANAGEMENT LP's COGT position evolved

SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in COGT in Q4 2024 at 910,865 shares (US$7.1M). The position peaked in Q2 2026 at 343,284 shares, worth US$13.3M. Across 7 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 343,284 shares valued at US$13.3M — an increase of 118,126 shares quarter over quarter.. Notable position changes include a 62% trim in Q3 2025 (shares rose 147% over the following quarter), a 39% trim in Q1 2026 (shares were roughly flat over the following quarter), a 52% increase in Q2 2026 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 910.87K $7.10M New
Q1 2025 774.72K $4.64M Reduce
Q2 2025 962.95K $6.91M Add
Q3 2025 361.41K $5.19M Reduce
Q4 2025 366.24K $13.01M Add
Q1 2026 225.16K $8.67M Reduce
Q2 2026 343.28K $13.29M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 60 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has SUPERSTRING CAPITAL MANAGEMENT LP held COGT?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed COGT holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in COGT?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 343.28K shares of COGT (COGENT BIOSCIENCES INC), valued at $13.29M, representing 8.39% of its reported portfolio and ranking #1.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling COGT?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP increased its position in COGT. The position peaked in Q2 2026 at 343.28K shares.

Which other funds hold COGT?

Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.